1. Home
  2. KTTA vs SNAL Comparison

KTTA vs SNAL Comparison

Compare KTTA & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.44

Market Cap

18.1M

Sector

Health Care

ML Signal

HOLD

Logo Snail Inc.

SNAL

Snail Inc.

BUY

Current Price

$2.27

Market Cap

21.2M

Sector

Technology

ML Signal

BUY

Company Overview

Basic Information
Metric
KTTA
SNAL
Founded
2020
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
18.1M
21.2M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
KTTA
SNAL
Price
$0.44
$2.27
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 141.8K
17.6K
Earning Date
11-12-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
77.07
★ 120.00
EPS
★ N/A
N/A
Revenue
$486,559.00
★ $81,225,622.00
Revenue This Year
N/A
$22.50
Revenue Next Year
N/A
$9.55
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 3130.37
N/A
52 Week Low
$0.28
$0.34
52 Week High
$2.06
$5.92

Technical Indicators

Market Signals
Indicator
KTTA
SNAL
Relative Strength Index (RSI) 35.47 31.82
Support Level $0.43 $0.44
Resistance Level $0.52 $2.70
Average True Range (ATR) 0.03 0.13
MACD -0.01 0.01
Stochastic Oscillator 9.01 28.18

Price Performance

Historical Comparison
KTTA
SNAL

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

About SNAL Snail Inc.

Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States. The Company has one operating and reportable segment. The company operates in the USA, the UK and Other Countries.

Share on Social Networks: